PROLACTINOMA IN WOMEN - CLINICAL AND BIOLOGICAL STUDY

被引：0
|
作者：
BEAUREGARD, H
VANCAMPENHOUT, J
RASIO, E
SOMMA, M
机构：
[1] HOP NOTRE DAME,DEPT OBSTET & GYNECOL,MONTREAL H2L 4K8,QUEBEC,CANADA
[2] HOP NOTRE DAME,UNITE METAB,MONTREAL H2L 4K8,QUEBEC,CANADA
[3] HOP NOTRE DAME,HORMONES POLYPEPTID LAB,MONTREAL H2L 4K8,QUEBEC,CANADA
[4] HOP NOTRE DAME,SERV ENDOCRINOL,MONTREAL H2L 4K8,QUEBEC,CANADA
[5] UNIV MONTREAL,FAC MED,MONTREAL H3C 3J7,QUEBEC,CANADA
来源：
NEUROCHIRURGIE | 1981年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：29 / 35
页数：7
相关论文
共 50 条
  • [21] An observational study of pregnancy and post-partum outcomes in women with prolactinoma treated with dopamine agonists
    O'Sullivan, Susannah M.
    Farrant, Maritza T.
    Ogilvie, Cara M.
    Gunn, Alistair J.
    Milsom, Stella R.
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2020, 60 (03): : 405 - 411
  • [22] Cabergoline-induced pregnancy in infertile women with prolactinoma
    Ono, Masami
    Miki, Nobuhiro
    Seki, Toshiro
    Makino, Rena
    Takano, Kazue
    ENDOCRINE JOURNAL, 2010, 57 : S509 - S509
  • [23] The PRolaCT studies — a study protocol for a combined randomised clinical trial and observational cohort study design in prolactinoma
    Ingrid M. Zandbergen
    Amir H. Zamanipoor Najafabadi
    Iris C. M. Pelsma
    M. Elske van den Akker-van Marle
    Peter H. L. T. Bisschop
    H. D. Jeroen Boogaarts
    Arianne C. van Bon
    Bakhtyar Burhani
    Saskia le Cessie
    Olaf M. Dekkers
    Madeleine L. Drent
    Richard A. Feelders
    Johan P. de Graaf
    J. Hoogmoed
    Kitty K. Kapiteijn
    Melanie M. van der Klauw
    Willy-Anne C. M. Nieuwlaat
    Alberto M. Pereira
    Aline M. E. Stades
    Annenienke C. van de Ven
    Iris M. M. J. Wakelkamp
    Wouter R. van Furth
    Nienke R. Biermasz
    Trials, 22
  • [24] Body weight and prolactinoma: a retrospective study
    H Soran
    J Wilding
    I MacFarlane
    International Journal of Obesity, 2004, 28 : 183 - 183
  • [25] Biological, clinical and ethical imperatives for involving diverse women in clinical trials
    Bekker, L-G
    Kamarulzaman, A.
    Orrell, C.
    Doherty, M.
    Little, M.
    Kwardem, L.
    Ross, M.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2020, 23 : 5 - 5
  • [26] Body weight and prolactinoma: a retrospective study
    Soran, H
    Wilding, J
    MacFarlane, I
    INTERNATIONAL JOURNAL OF OBESITY, 2004, 28 (01) : 183 - 183
  • [27] Giant Prolactinoma in Men: Clinical Features and Therapeutic Outcomes
    Iglesias, Pedro
    Arcano, Karina
    Rodriguez Berrocal, Victor
    Bernal, Carmen
    Villabona, Carles
    Jose Diez, Juan
    HORMONE AND METABOLIC RESEARCH, 2018, 50 (11) : 791 - 796
  • [28] Body fat in nonobese women with prolactinoma treated with dopamine agonists
    Naliato, Erika C. O.
    Violante, Alice H. D.
    Caldas, Dayse
    Lamounier Filho, Adilson
    Loureiro, Christiane R.
    Fontes, Rosita
    Schrank, Yolanda
    Souza, Rodrigo G.
    Costa, Patricia L. M.
    Colao, Annamaria
    CLINICAL ENDOCRINOLOGY, 2007, 67 (06) : 845 - 852
  • [29] MULTIVARIATE STATISTICAL INTERPRETATION OF CLINICAL DATA OF PROLACTINOMA PATIENTS
    Georgieva-Nikolova, Radka
    Kamenov, Zdravko
    Slavova, Miglena
    Nikolov, Marian
    Simeonov, Vasil
    ECOLOGICAL CHEMISTRY AND ENGINEERING A-CHEMIA I INZYNIERIA EKOLOGICZNA A, 2013, 20 (4-5): : 585 - 594
  • [30] Chemometric Expertise Of Clinical Monitoring Data Of Prolactinoma Patients
    Nedyalkova, Miroslava
    Dimitrov, Dimitar
    Donkova, Borjana
    Simeonov, Vasil
    OPEN CHEMISTRY, 2019, 17 (01): : 408 - 412
12345